Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Eur J Nutr ; 58(6): 2263-2270, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30019089

RESUMO

PURPOSE: Nonalcoholic steatohepatitis (NASH) is characterized by steatosis, lobular inflammation, ballooning, and in some cases, fibrosis, which can progress to cirrhosis and carcinoma. The progression of NASH is closely related to oxidative stress. Dietary intake of antioxidants has been suggested in protection against oxidative damage and related clinical complications. Thus, we evaluated the potential association of dietary total antioxidant capacity (TAC) with disease severity in NASH patients, as well as with anthropometric and body composition markers and biochemical parameters. METHODS: Thirty-three outpatients with a mean age of 48.4 ± 1.9 years were evaluated. Dietary TAC was estimated from a quantitative food frequency questionnaire. NASH severity, determined by liver biopsy, lifestyle characteristics, occurrence of comorbidities, anthropometry, body composition, and biochemical parameters were assessed. RESULTS: NASH patients who had a higher dietary TAC had fewer ballooned hepatocytes compared to those with a lower TAC (p = 0.024). The patients with the highest dietary TAC had a reduction of approximately 20% in the risk of having many ballooned hepatocytes (OR 0.791; 95% CI 0.643-0.974; p = 0.027). There was no association of steatosis, lobular inflammation, and fibrosis with dietary TAC. The same occurred for lifestyle characteristics, occurrence of comorbidities, anthropometry, body composition, and biochemical parameters. CONCLUSION: Dietary TAC is higher in patients with lower hepatic injury (ballooning), suggesting a possible role of food intake naturally high in its antioxidant capacity in reducing free radical production and, consequently, oxidative stress.


Assuntos
Antioxidantes/farmacologia , Dieta/métodos , Hepatócitos/patologia , Hepatopatia Gordurosa não Alcoólica/dietoterapia , Antioxidantes/administração & dosagem , Estudos Transversais , Feminino , Hepatócitos/efeitos dos fármacos , Humanos , Fígado/patologia , Masculino , Pessoa de Meia-Idade , Hepatopatia Gordurosa não Alcoólica/patologia , Estresse Oxidativo/efeitos dos fármacos , Índice de Gravidade de Doença , Inquéritos e Questionários
2.
Eur J Nutr ; 57(3): 861-876, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28875318

RESUMO

INTRODUCTION: Nonalcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation, and ballooning degeneration of hepatocytes, with or without fibrosis. The prevalence of NASH has increased with the obesity epidemic, but its etiology is multifactorial. The current studies suggest the role of gut microbiota in the development and progression of NASH. The aim is to review the studies that investigate the relationship between gut microbiota and NASH. These review also discusses the pathophysiological mechanisms and the influence of diet on the gut-liver axis. RESULT: The available literature has proposed mechanisms for an association between gut microbiota and NASH, such as: modification energy homeostasis, lipopolysaccharides (LPS)-endotoxemia, increased endogenous production of ethanol, and alteration in the metabolism of bile acid and choline. There is evidence to suggest that NASH patients have a higher prevalence of bacterial overgrowth in the small intestine and changes in the composition of the gut microbiota. However, there is still a controversy regarding the microbiome profile in this population. The abundance of Bacteroidetes phylum may be increased, decreased, or unaltered in NASH patients. There is an increase in the Escherichia and Bacteroides genus. There is depletion of certain taxa, such as Prevotella and Faecalibacterium. CONCLUSION: Although few studies have evaluated the composition of the gut microbiota in patients with NASH, it is observed that these individuals have a distinct gut microbiota, compared to the control groups, which explains, at least in part, the genesis and progression of the disease through multiple mechanisms. Modulation of the gut microbiota through diet control offers new challenges for future studies.


Assuntos
Disbiose/fisiopatologia , Medicina Baseada em Evidências , Microbioma Gastrointestinal , Fígado/fisiopatologia , Modelos Biológicos , Hepatopatia Gordurosa não Alcoólica/etiologia , Animais , Ácidos e Sais Biliares/metabolismo , Colina/metabolismo , Dieta/efeitos adversos , Progressão da Doença , Disbiose/imunologia , Disbiose/metabolismo , Disbiose/microbiologia , Endotoxemia/etiologia , Endotoxemia/imunologia , Endotoxemia/microbiologia , Endotoxemia/fisiopatologia , Ingestão de Energia , Metabolismo Energético , Etanol/metabolismo , Fermentação , Microbioma Gastrointestinal/imunologia , Humanos , Lipopolissacarídeos/biossíntese , Lipopolissacarídeos/toxicidade , Fígado/imunologia , Fígado/metabolismo , Hepatopatia Gordurosa não Alcoólica/imunologia , Hepatopatia Gordurosa não Alcoólica/microbiologia , Hepatopatia Gordurosa não Alcoólica/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA